help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thomas, G.
Right arrow Articles by Debuire, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thomas, G.
Right arrow Articles by Debuire, B.

Journal of Clinical Endocrinology & Metabolism, Vol 79, 1273-1276, Copyright © 1994 by Endocrine Society


ARTICLES

Serum dehydroepiandrosterone sulfate levels as an individual marker

G Thomas, N Frenoy, S Legrain, R Sebag-Lanoe, EE Baulieu and B Debuire
Departement de Biostatistique et Informatique Medicale, Hopital Saint- Louis, Paris.

To assess the significance of the serum dehydroepiandrosterone sulfate (DHEAS) concentration as a parameter of the individual hormonal milieu, two different groups of subjects were studied: DHEAS levels were determined 3 times at 6-month intervals in 47 elderly hospitalized women, aged 71-94 yr (group 1), and 6 times over 2 consecutive weeks in 10 healthy male volunteers, aged 24-30 yr (group 2). For reference, serum cortisol (F) levels were determined concomitantly. In each group and on each sampling occasion, the subjects were ranked according to their DHEAS or F values. The stability over time of the ranking was much higher for DHEAS than for F; estimated concordance coefficients were 92% (group 1) and 88% (group 2) for DHEAS vs. 51% (group 1) and 49% (group 2) for F. We conclude that due to a comparatively low within- to between-subject variability ratio, DHEAS is a highly specific individual marker.


This article has been cited by other articles:


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
A. R. Cappola, Q.-L. Xue, J. D. Walston, S. X. Leng, L. Ferrucci, J. Guralnik, and L. P. Fried
DHEAS Levels and Mortality in Disabled Older Women: The Women's Health and Aging Study I.
J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2006; 61(9): 957 - 962.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. O. Yildiz, K. S. Woods, F. Stanczyk, A. Bartolucci, and R. Azziz
Stability of Adrenocortical Steroidogenesis over Time in Healthy Women and Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5558 - 5562.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
V. H. Boonstra, P. G. H. Mulder, F. H. de Jong, and A. C. S. Hokken-Koelega
Serum Dehydroepiandrosterone Sulfate Levels and Pubarche in Short Children Born Small for Gestational Age before and during Growth Hormone Treatment
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 712 - 717.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
G. Percheron, J.-Y. Hogrel, S. Denot-Ledunois, G. Fayet, F. Forette, E.-E. Baulieu, M. Fardeau, and J.-F. Marini
Effect of 1-Year Oral Administration of Dehydroepiandrosterone to 60- to 80-Year-Old Individuals on Muscle Function and Cross-sectional Area: A Double-blind Placebo-Controlled Trial
Arch Intern Med, March 24, 2003; 163(6): 720 - 727.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. S. Legro, A. R. Kunselman, L. Demers, S. C. Wang, R. Bentley-Lewis, and A. Dunaif
Elevated Dehydroepiandrosterone Sulfate Levels as the Reproductive Phenotype in the Brothers of Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2134 - 2138.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. S. C. Yen
Dehydroepiandrosterone sulfate and longevity: New clues for an old friend
PNAS, July 17, 2001; 98(15): 8167 - 8169.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Mazat, S. Lafont, C. Berr, B. Debuire, J.-F. Tessier, J.-F. Dartigues, and E.-E. Baulieu
Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: Relationship to gender, subjective health, smoking habits, and 10-year mortality
PNAS, June 20, 2001; (2001) 121177998.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Azziz, L. M. Fox, H. A. Zacur, C. R. Parker Jr., and L. R. Boots
Adrenocortical Secretion of Dehydroepiandrosterone in Healthy Women: Highly Variable Response to Adrenocorticotropin
J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2513 - 2517.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
L. Ibáñez, J. DiMartino-Nardi, N. Potau, and P. Saenger
Premature Adrenarche--Normal Variant or Forerunner of Adult Disease?
Endocr. Rev., December 1, 2000; 21(6): 671 - 696.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Legrain, C. Massien, N. Lahlou, M. Roger, B. Debuire, B. Diquet, G. Chatellier, M. Azizi, V. Faucounau, H. Porchet, et al.
Dehydroepiandrosterone Replacement Administration: Pharmacokinetic and Pharmacodynamic Studies in Healthy Elderly Subjects
J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3208 - 3217.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Remer and F. Manz
Role of Nutritional Status in the Regulation of Adrenarche
J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 3936 - 3944.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
G.P. Bernini, M. Sgro’, A. Moretti, G.F. Argenio, C.O. Barlascini, R. Cristofani, and A. Salvetti
Endogenous Androgens and Carotid Intimal-Medial Thickness in Women
J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2008 - 2012.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. A. Lane, D. K. Ingram, S. S. Ball, and G. S. Roth
Dehydroepiandrosterone Sulfate: A Biomarker of Primate Aging Slowed by Calorie Restriction
J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2093 - 2096.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Berr, S. Lafont, B. Debuire, J.-F. Dartigues, and E.-E. Baulieu
Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: A French community-based study
PNAS, November 12, 1996; 93(23): 13410 - 13415.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Mazat, S. Lafont, C. Berr, B. Debuire, J.-F. Tessier, J.-F. Dartigues, and E.-E. Baulieu
Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: Relationship to gender, subjective health, smoking habits, and 10-year mortality
PNAS, July 3, 2001; 98(14): 8145 - 8150.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society